      .  II.    
  


     ,             .      90  ,   - ,    .     330 ,            .   ?          ,     .        .






  




COX-2 ? -2; ,   



IFN-? ? -; ,  

in vitro ?  ,   

in vivo ?  ,     

NF-?B ?   -; ,  

   

NOS ?   ; 

Th1, Th2 ? -;   

TNF-? ?   -;  

?- ?   ,  

 ? ;  

 ? ;  

 ? - ; 

, IL ? ; ,   

   

 ?    ( )

 ?    ( )




 ,  





7- (7-keto DHEA)

7- DHEA       (DHEA),  .    DHEA, 7-keto DHEA     .   7-keto DHEA,        ,    .  7-keto DHEA     ,   ,     .

 

   .

       7-keto DHEA   . ,   A randomized, double-blind, placebo-controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweight adults, 2000 [https://www.sciencedirect.com/science/article/pii/S0011393X00800260],  200  7-keto DHEA   8                  ,      .

 

 .

  

  7-keto DHEA  200-400        (100-200 )

  

     7-keto DHEA   .




PRL-8-53


PRL-8-53 (-3 (2 ( () ) ) ) ?  ,  .      1970-     (Nikolaus Hensl).    PRL-8-53 ?   ,  ,    , ,      .

 

   .

PRL-8-53    , ,     .   PRL-8-53   .      PRL-8-53: enhanced learning and subsequent retention in humans as a result of low oral doses of new psychotropic agent,   1978 [https://www.ncbi.nlm.nih.gov/pubmed/418433]         .         .

  

 ,  .

  

     5 .         20 /.

 

    PRL-8-53   .



   ,    L-.       .        ,  ,     .    ,      .       .

 

.

   ,             [Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model, 2014. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990080/].   Suppression of MicroRNA let-7a expression by agmatine regulates neural stem cell differentiation, 2016 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011279/]  ,         .          .

  .

    ( ),      ,   ,   ,    ,   ,          ,    ,         .

  

 .

  

         ,       .  :

   : 1000-2500 /;

   : 200-500  /;

      : 500-1000   30   .

 

    , , .

- (L--L-, )

L-  - ,  , ,    .       ,        ,       . -    ,    ? L-  L-,     .

 

  .

-        .             . ,   Effects of l-Alanyl-l-Glutamine Ingestion on One-Hour Run Performance, 2015 [https://www.ncbi.nlm.nih.gov/pubmed/26098280]  ,   -   ,               .

 

 .

  

  L--L-  1-3 /.

 

 L--L-    , , .

- 

-  (,  ,  )    ,      .      ,         ,    ,       ,       ,      ,     ,     .

           ;       .     (  , , - )     .   -  ?  (, ,   .)    ( , ,   .).

 

   .

           .         (   Q


),        [Physiological effect and therapeutic application of alpha lipoic acid, 2014. URL: https://www.ncbi.nlm.nih.gov/pubmed/25005184].

  .

  ,    -       . ,   Alpha-lipoic acid (ALA) as a supplementation for weight loss, 2017 [https://www.ncbi.nlm.nih.gov/pubmed/28295905]        ,   -       .

 .

       ,         [Ambrosi N. et al., Transplantation, 2016. URL: https://www.ncbi.nlm.nih.gov/pubmed/26502371].

 .

       .      ( ),     .      2       ,        [https://www.ncbi.nlm.nih.gov/pubmed/21666939].

 - .

    The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress, 2015 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407629/]        ,      ,       .    ,       I ?   .  ,        ? ,   .   ,         ,        ,  ,  .

 .

-          ,       .     Alpha-lipoic acid treatment is neurorestorative and promotes functional recovery after stroke in rats, 2015 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339247/]             .   Potential therapeutic effects of lipoic acid on memory deficits related to aging and neurodegeneration, 2017 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732919/],         /    (,    .),      .

 .

 ?-lipoic acid treatment improves vision-related quality of life in patients with dry age-related macular degeneration, 2016 [https://www.jstage.jst.go.jp/article/tjem/240/3/240_209/_pdf/-char/en] ,            ,     .

 .

   Emerging role of alpha-lipoic acid in the prevention and treatment of bone loss, 2015 [https://www.ncbi.nlm.nih.gov/pubmed/26024498] -        ,     .

 .

     ,          [Moon H.S., 2016. URL: https://www.karger.com/Article/FullText/443994].

 

   -   .

  

          .           50-100 .       600-800 ,     ?  1800 .

 

  -   ,      ,      .    ,    : , , ,  ,     .




 (N-, )


        .  ,           ,   ,  ,    ,  , ,  , ,      /  .     ,        .

 

 .

      ,        ,       .   The application of N-acetylcysteine in optimization of specific pharmacological therapies, 2017 [https://www.ncbi.nlm.nih.gov/pubmed/28987048]       .

 .

  ,             .         (OH),   (NO


)     (CO


),      .  ,   ()    (Cu


, Fe


),      (Cd


, Hg





, Pb





),       .    ,            [Pei Y. et al., 2018. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937417/].

 .

  NF-?B            ,    .        NF-?B.          ,   -1?, -6  -8,   -? (TNF-?)     ? (TGF-?)   [The effect of N-acetylcysteine and calcium hydroxide on TNF-? and TGF-?1 in lipopolysaccharide-activated macrophages, 2016. URL: https://www.ncbi.nlm.nih.gov/pubmed/27061477/].

 .

  ,     ,    .   Biological activities and potential oral applications of N-Acetylcysteine: progress and prospects, 2018 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937417/]         Staphylococcus epidermidis, Enterococcus faecalis, Actinomyces naeslundii, Lactobacillus salivarius  Streptococcus mutans.

 .

             ,         .    ,         ,       ,     ,   ,     ,    ,     ,  ,  ,         [Pei Y. et al., 2018. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937417/].

  .

       ,    ,    , ,    ,   ,  ,   ,  ,   - .

  

   .

  

       300 /  .

 

     , ,   .





 ?    


 ().             .       B


      ,     .

 

  .

      .          . ,   ,   Benfotiamine in diabetic polyneuropathy, 2008 [https://www.ncbi.nlm.nih.gov/pubmed/18473286]         6 .      ,    ,    ,   .

  .

 Long-term cognitive improvement after benfotiamine administration in patients with Alzheimer's disease, 2017 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567484/]       .          18    300   .              3,2    Mini-Mental Status Examination.

 .

  Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages, 2010 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856750/]    .       ,    ? .      ,     ,   ,     .

  .

        ,     ,        .

 

     


.

  

  ,       300-600 /,    .

 

        ,     .

 (MGN-3)

MGN-3  ,    ,      .              .

 

 .

  ,        . ,   Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects, 2018 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795547/]   56        30 .           ?  ,        .     .  ,          ,    .

  .

          , , , ,       .

 

 .

  

  ,    ,  500 /    30 .

 

        ,          .







      1960-    ,       (Vinca minor).  1978               , , ,      ,    .        .

 

.

  Role of vinpocetine in cerebrovascular diseases, 2011 [http://www.if-pan.krakow.pl/pjp/pdf/2011/3_618.pdf] ,         .        ,   ,  Na-    .          .    ,                         .  ,              .  ,      ,          , ,  , .

 .

 ?  ,     .           .         .     ,      .   - (NF-?B)         .   Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke, 2016 [http://www.mdpi.com/1420-3049/20/1/335/htm] ,  ,    ,   ,         ,    ,    ,  ,    .

  .

  ,  ,  ,  ,    ,   , ,     .

  

  , ,   .

  

     10  3   .

 

      , - .


 / (

DHE

)

 (DHE)   ,  5-HT1B/1D-        1946 .             ,    ,  DHE      .       DHE       ( ).

 

    .

 ,  DHE      . ,      Aurora S.K. et al., 2009 [https://www.ncbi.nlm.nih.gov/pubmed/19545249]        72%    2 ,   ,        ,         10   .   MAP0004, orally inhaled DHE, 2011 [https://www.ncbi.nlm.nih.gov/pubmed/21457235]   ,   DHE         ,     8    .

  

,  .

  

  : 0,6-1,0 .

 

   1   ,    .



 ?  ,   ,    .          -.  95%      - ,   5% ?  ,   .     ?    ,        ().    ,        : ,   ,   -    .

 

    .

  Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults, 2017 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679696/]   22      ,         .   721     57-70             7-52 .  ,          () ,        ,        .

   .

  Effects of creatine supplementation on cognitive function of healthy individuals, 2018 [https://www.ncbi.nlm.nih.gov/pubmed/29704637]       .  ,            ()   .    A review of creatine supplementation in age-related diseases: more than a supplement for athletes, 2014 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304302/]        .  :            ,   , ,   ,   ,     ,   .

 .

  Beyond muscles: The untapped potential of creatine, 2016 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915971/] ,                 .  ,  ,     ,              (). ,  40      ABTS







  .


   .

   ,     (https://www.litres.ru/vadim-urevich-mayoro/legalnye--37926626/)  .

      Visa, MasterCard, Maestro,    ,   ,     ,  PayPal, WebMoney, ., QIWI ,       .


